AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIOXYNE LIMITED Capital/Financing Update 2021

Nov 3, 2021

Capital/Financing Update

Opens in your device viewer

==> picture [594 x 137] intentionally omitted <==

4 November 2021

Bioxyne Limited (ASX:BXN) ( Company ) refers to the request for voluntary suspension lodged with the ASX on 29 October 2021.

The Company advises that it has determined not to proceed with the proposed acquisition at this time.

This announcement has been approved by the Board.

Guy Robertson Company Secretary

Bioxyne Limited ABN 97 084 464 193, Suite 506, Level 5 50 Clarence Street, Sydney NSW 2000 E [email protected] W www.bioxyne.com